Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 30, 2007, Pages 12474-12478

  Skelly, Christopher L ^a   Chandiwal, Amito ^a   Vosicky, James E ^a   Weichselbaum, Ralph R ^a   Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Endothelial cells; Neointimal hyperplasia; Restenosis; Vascular smooth muscle cells

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTERY LIGATION; ARTERY WALL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENETIC ENGINEERING; HERPES SIMPLEX VIRUS 1; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; RESTENOSIS; VASCULAR SMOOTH MUSCLE;

ANGIOPLASTY, BALLOON; ANIMALS; APOPTOSIS; ARTERIES; CASPASE 3; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HERPESVIRUS 1, HUMAN; HYPERPLASIA; MALE; MUTATION; PROLIFERATING CELL NUCLEAR ANTIGEN; RABBITS; REGIONAL BLOOD FLOW;

HUMAN HERPESVIRUS 1;

EID: 34547625062     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0705429104     Document Type: Article

References (17)

1. American Heart Association (2007) Heart Disease and Stroke Statistics: 2007 Update (Am Heart Assoc, Dallas). Available at http://www. americanheart.org/downloadable/heart/1166711577754HS_StatsInsideText.pdf. Accessed April 2, 2007.
2. Williams DO, Holubkov R, Yeh W, Bourassa MG, Al-Bassam M, Block PC, Coady P, Cohen H, Cowley M, Dorros G, et al. (2000) Circulation 102:2910-2914.
3. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T,Suddath WO, Weissman NJ, Torguson R, Kent KM, et al. (2004) Lancet 236:1519-2151.
4. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, et al. (2006) Circulation 113:1108-1113.
5. Hanke H, Hassenstein S, Ulmer A, Kamenz J, Oberhoff M, Haase KK, Baumbach A, Gown AM, Karsch KR (1994) Eur Heart J 15:691-698.
6. Clowes AW, Reidy MA, Clowes MM (1983) Lab Invest 49:208-215.
7. Kemeny N, Brown K, Covey A, Kim T, Bhargava A, Brody L, Guilfoyle B, Haag NP, Karrasch M, Glassschroeder B, et al. (2006) Hum Gene Ther 17:1214-1224.
8. Harrow S, Papanastassiou V, Harland J, Mabbs R, Petty R, Fraser M, Hadley D, Patterson J, Brown SM, Rampling R (2004) Gene Ther 11:1648-1658.
9. Detta A, Harland J, Hanif I, Brown SM, Cruickshank GJ (2003) Gene Med 5:681-689.
10. Shah AC, Benos D, Gillespie GY, Markert JM (2003) J Neuro-Oncol 65:203-226.
11. Papanastassiou V, Rampling R, Fraser M, Petty R, Hadley D, Nicoll J, Harland J, Mabbs R, Brown SM (2002) Gene Ther 9:398-406.
12. Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD, Palmer CA, Feigenbaum F, Tornatore C, Tufaro F, et al. (2000) Gene Ther 7:859-866.
13. Skelly CL, Curi MA, Meyerson SL, Woo DH, Hari D, Vosicky JE, Advani SJ, Mauceri HJ, Glagov S, Roizman B, et al. (2001) Gene Ther 8:1840-1846.
14. Roizman B, Knipe DM, Whitley RJ (2007) in Fields' Virology, eds Knipe DM, Howley P, Griffin DE, Lamb RA, Martin A, Roizman B, Straus SE (Lippincott, New York), 5th Ed, pp 2501-2601.
15. Meigner B, Longnecker R, Roizman B (1988) J Infect Dis 158:602-614.
16. Meigner B, Longnecker R, Roizman B (1990) J Infect Dis 162:313-321.
17. Ide M, Jimbo M, Yamamoto M, Kubo O (1997) Neurol Med Chir (Tokyo) 37:158-162.